PSMD6-AS2: A Potential Drug Target and Biomarker (G100507062)

Target Name: PSMD6-AS2

NCBI ID: G100507062

PSMD6-AS2

Other Name(s): PSMD6 antisense RNA 2

PSMD6-AS2: A Potential Drug Target and Biomarker

PSMD6-AS2, short for poly (stimulated by mental-associative memories) protein-6 and AS2, is a protein that is expressed in the brain and has been implicated in a number of neurological and psychiatric disorders. Despite its prevalence, the exact function of PSMD6-AS2 is not well understood. However, research has identified several potential drug targets and biomarkers associated with this protein.

The protein encoded by PSMD6-AS2 is a member of the PSMD6 family, which is known for its role in regulating synaptic plasticity and memory. PSMD6-AS2 is expressed in various tissues and has been shown to play a role in the formation of memory traces and the regulation of neurotransmitter release.

One of the most promising drug targets for PSMD6-AS2 is its role in the regulation of memory and learning. Several studies have shown that PSMD6-AS2 is involved in the formation of long-term memories and that alterations in its expression have been linked to a number of memory impairments, including Alzheimer's disease.

In addition to its role in memory, PSMD6-AS2 has also been shown to be involved in the regulation of emotional behavior. Studies have shown that PSMD6-AS2 is involved in the regulation of emotional expression and that alterations in its expression have been linked to a number of psychiatric disorders, including depression and anxiety.

Another potential drug target for PSMD6-AS2 is its role in the regulation of neurotransmitter release. Studies have shown that PSMD6-AS2 is involved in the regulation of neurotransmitter release and that alterations in its expression have been linked to changes in neurotransmitter levels and neurotransmission.

In addition to its potential drug targets and biomarkers, PSMD6-AS2 has also been shown to have potential as a diagnostic tool. Studies have shown that PSMD6-AS2 is expressed in the brain and that alterations in its expression have been linked to a number of neurological and psychiatric disorders. This suggests that PSMD6-AS2 may be a useful biomarker for the diagnosis of these disorders.

Overall, while more research is needed to fully understand the role of PSMD6-AS2 in the brain, its potential as a drug target and biomarker is an exciting area of study. Further research is likely to lead to new insights into the biology of this protein and its potential as a therapeutic intervention.

Protein Name: PSMD6 Antisense RNA 2

The "PSMD6-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSMD6-AS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets